Nicolas Brechot
Overview
Explore the profile of Nicolas Brechot including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
108
Citations
3091
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Stiel L, Gaudet A, Thietart S, Vallet H, Bastard P, Voiriot G, et al.
Ann Intensive Care
. 2024 Sep;
14(1):137.
PMID: 39227416
Background: Activation of innate immunity is a first line of host defense during acute critical illness (ACI) that aims to contain injury and avoid tissue damages. Aberrant activation of innate...
3.
Azoulay L, Frapard T, Larcher R, Pene F, Argaud L, Mayaux J, et al.
Clin Rheumatol
. 2024 Jul;
43(9):2889-2898.
PMID: 39073513
Objectives: Severe thrombotic antiphospholipid syndrome (APS) frequently affects the kidney, heart, and central nervous system. The precise frequency, clinical picture, differential diagnoses, and outcome of APS-related hematological involvement are lacking,...
4.
Benghanem S, Sharshar T, Gavaret M, Dumas F, Diehl J, Brechot N, et al.
Resuscitation
. 2024 Jun;
202:110294.
PMID: 38925291
Background: Hypoxic ischemic brain injury (HIBI) induced by cardiac arrest (CA) seems to predominate in cortical areas and to a lesser extent in the brainstem. These regions play key roles...
5.
Masi P, Gendreau S, Moyon Q, Leguyader M, Lebreton G, Ropers J, et al.
J Crit Care
. 2024 Mar;
82:154771.
PMID: 38471248
Purpose: Management of dual antiplatelet therapy (DAPT) in patients on venoarterial-extracorporeal membrane (VA-ECMO) after acute myocardial infarction (AMI) is challenging. Our objective was to describe the frequency, management and outcomes...
6.
Marquet Y, Hekimian G, Lebreton G, Kerneis M, Rouvier P, Bay P, et al.
Ann Intensive Care
. 2023 Aug;
13(1):78.
PMID: 37653258
Background: Fulminant myocarditis is a rare and severe disease whose definite and etiological diagnoses rely on pathological examination. Albeit, myocardial biopsy can be associated with significant morbidity and mortality, its...
7.
Guerin E, Belin L, Franchineau G, Le Guennec L, Hajage D, Diallo M, et al.
Crit Care
. 2023 Aug;
27(1):331.
PMID: 37641136
Background: Vascular leakage is a major feature of acute respiratory distress syndrome (ARDS). We aimed to evaluate the efficacy of FX06, a drug under development that stabilizes interendothelial cell junctions,...
8.
Brechot N, Rutault A, Marangon I, Germain S
Semin Cell Dev Biol
. 2023 Jul;
155(Pt C):16-22.
PMID: 37479554
In the human body, the 10 blood endothelial cells (ECs) which cover a surface of 500-700 m (Mai et al., 2013) are key players of tissue homeostasis, remodeling and regeneration....
9.
Danial P, Olivier M, Brechot N, Ponnaiah M, Schoell T, DAlessandro C, et al.
J Am Coll Cardiol
. 2023 Mar;
81(9):897-909.
PMID: 36858709
Background: Outcomes of patients requiring venoarterial extracorporeal membrane oxygenation (VA-ECMO) vary greatly by etiology, but large studies that incorporate the spectrum of shock supported with ECMO are rare. Objectives: The...
10.
Chommeloux J, Montero S, Franchineau G, Lebreton G, Brechot N, Barhoum P, et al.
J Crit Care
. 2022 Nov;
72:154193.
PMID: 36436880
No abstract available.